Discovering old motorcycles/ by 455886 Crowley, R. E.

Die design fundamentals by 335574 Paquin, J. R., Crowley, R. E.

James Joyce's Unpublished Letters [online resource] by Van Hulle, D, Spoo, R, Groden, M, Dettmar, K, Crowley, R, Brockman, WS, Batinić, J, Alonso, S

Androgenemic Phenotype Predicts Metabolic Disease and Androgen Burden in Polycystic Ovary Syndrome by O'Reilly, M, Taylor, A, Crabtree, N, Crowley, R, Hughes, B, Stewart, P, Tomlinson, J, Arlt, W

SFRP2 is associated with increased adiposity and VEGF expression. by Crowley, R, O'Reilly, M, Bujalska, I, Hassan-Smith, Z, Hazlehurst, J, Foucault, D, Stewart, P, Tomlinson, J

Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione. by O'Reilly, M, Taylor, A, Crabtree, N, Hughes, B, Capper, F, Crowley, R, Stewart, P, Tomlinson, J, Arlt, W

Longitudinal changes in glucocorticoid metabolism are associated with later development of adverse metabolic phenotype. by Crowley, R, Hughes, B, Gray, J, McCarthy, T, Hughes, S, Shackleton, C, Crabtree, N, Nightingale, P, Stewart, P, Tomlinson, J

Preparing accessible and understandable clinical research participant information leaflets and consent forms: a set of guidelines from an expert consensus conference by Coleman, E, O'Sullivan, L, Crowley, R, Hanbidge, M, Driver, S, Kroll, T, Kelly, A, Nichol, A, McCarthy, O, Sukumar, P, Doran, P

Increased central adiposity and decreased subcutaneous adipose tissue 11β‐hydroxysteroid dehydrogenase type 1 are associated with deterioration in glucose tolerance—A longitudinal... by Crowley, R, Woods, C, Hughes, B, Gray, J, McCarthy, T, Taylor, A, Gathercole, L, Shackleton, C, Crabtree, N, Arlt, W, Stewart, P, Tomlinson, J

Advanced non-alcoholic fatty liver disease and adipose tissue fibrosis in patients with Alstrom syndrome. by Gathercole, L, Hazlehurst, J, Armstrong, M, Crowley, R, Boocock, S, O'Reilly, M, Round, M, Brown, R, Bolton, S, Cramb, R, Newsome, P, Semple, R, Paisey, R, Tomlinson, J, Geberhiwot, T

Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Contro... by Portale, A, Carpenter, T, Brandi, M, Briot, K, Cheong, H, Cohen-Solal, M, Crowley, R, Jan De Beur, S, Eastell, R, Imanishi, Y, Imel, E, Ing, S, Ito, N, Javaid, M, Kamenicky, P, Keen, R, Kubota, T, Lachmann, R, Perwad, F, Pitukcheewanont, P, Ralston, S, Takeuchi, Y, Tanaka, H, Weber, T, Yoo, H, Zhang, L, Theodore-Oklota, C, Mealiffe, M, San Martin, J, Insogna, K